Previous close | 18,726.76 |
Open | 18,731.65 |
Volume |
Day's range | 18,642.20 - 18,731.65 |
52-week range | 14,630.21 - 18,892.92 |
Avg. volume | 73,819,733 |
The region-wide index, home to popular large-cap stocks such as drugmaker Novo Nordisk and tech group ASML is set to rise again in 2025, reaching 537 by end-June and a lifetime high of 556 by year-end. "European equities have had a strong first half of the year and it is possible they hit pause over the summer months," said Moz Afzal, Global CIO of EFG Asset Management in London. In the upbeat camp is Barclays strategist Emmanuel Cau who remains "tactically" overweight on Europe.
Investors are looking to corporates for a cue in the absence of top-level economic data releases.
European stock markets slipped lower Tuesday, as the positive momentum at the start of the week stalled amid concerns of U.S. interest rates staying higher for longer than expected. Trading ranges have been limited so far this week as investors waited for the release of the minutes of the Federal Reserve's latest policy meeting to gauge the timing and extent of possible interest rate cuts this year in the world’s largest economy. There are more Fed speakers to digest Tuesday, including Barr once more, as well as FOMC members Thomas Barkin, John Williams and Raphael Bostic.